| Application no. and date | 17850396.7 (espacenet) (Federated) (European Patent Register), 20170915 | | Patent/reg. no. and date | DK/EP 3512570, 20240828 | | Publication date | 20190724 | | Priority no. and date | US 201662395836 P, 20160916 | | EP pub. no. and date |
EP 3512570 20190724 | | Effective date | | | Applicant/owner | Texas Children's Hospital, 1102 Bates Street
Suite 850
Feigin Center
Houston, TX 77030, US | | Applicant ref. no. | | | Inventor | ANNAPRAGADA, Ananth, 3114 Spring Ridge Drive
Manvel, TX 77578, US,
SHETTY, Anil, 5810 Lowther Landing Court
Sugarland, TX 77479, US,
GHAGHADA, Ketankumar B., 4611 Stoney Ridge Court
Sugarland, TX 77479, US,
TANIFUM, Eric, 7306 Branford Park Ln
Richmond, TX 77407, US | | Representative | | | Opponent | | | IPC Class | A61B 5/055 (2006.01) , A61K 49/08 (2006.01) , A61K 49/10 (2006.01) , A61K 49/12 (2006.01) , A61K 49/18 (2006.01) , C07F 5/00 (2006.01) | | Title | NOVEL LIPOSOMAL GADOLINIUM (GD) CONTRAST AGENT "NMRX" FOR T1-MRI | | Int. application no. | IB2017055611 | | Int. publication no. | WO2018051289 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
